Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib as a Treatment for Patients with COVID-19 Associated Cytokine Storm
Incyte announced the Company is working with the U.S. FDA to initiate a Phase 3 clinical trial (RUXCOVID) to evaluate...